Office of Extramural Research (OER) Web Site
NIH R34 Parent Program Announcement (PA-09-186)

Contacts and Special Interests
Release Date: May 15, 2009
Expiration Date: May 8, 2012

Introduction

The NIH Clinical Trial Planning Grant Program (R34) supports development of Phase III clinical trials. This program supports

  • establishment of the research team,
  • development of tools for data management and research oversight
  • definition of recruitment strategies,
  • finalization of the protocol
  • preparation of an operations/procedures manual

The Clinical Trial Planning Grant is not designed for the collection of preliminary data or the conduct of pilot studies to support the rationale for a clinical trial.

The R34 Parent Funding Opportunity Announcement for investigator-initiated R34 applications can be found at PA-09-186 and articulates the policies and procedures that apply to this program.

This website describes the use of the investigator-initiated R34 and describes the NIH Institutes and Centers (ICs) that intend to accept such applications.

R34 Participating Institutes and Centers

R34 Non-Participating Institutes and Centers

  • NIH Institutes and Centers that DO NOT accept investigator initiated applications in response to this Parent R34 Announcement but ONLY accept Institute  specific Funding Opportunity Announcements for Clinical Trial Planning Grant (R34): NCCAM, NCI, NCRR, NHGRI, NHLBI, NIAID, NIBIB, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, and FIC.

NIH Institute and Center Contacts and Scientific Research Areas of Interest

NIH Institute/Center
Scientific/Research Contact
Financial or Grants Management Contact

NIH Institutes, Centers, and Offices that Accept NIH Clinical Trial Planning Grant (R34) Applications Under Parent Funding Opportunity Announcement (FOA), PA-09-186

National Institute on Aging (NIA)

Dr. Sergei Romashkan
Phone: 301-435-3047
FAX: 301-480-1066
Email:  Romashks@mail.nih.gov

Linda Whipp
Phone: 301-496-1472
FAX: 301-402-3672
Email:  whippL@mail.nih.gov

The National Institute on Aging (NIA) will accept investigator-initiated R34 applications for all program areas supported by the Institute.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Margaret E. Mattson, Ph.D.
Phone: 301-443-0638
FAX: 301-443-8774
Email: mmattson@mail.nih.gov

Judy Fox
Phone: 301-443-4704
FAX: 301-443-3891
Email:  jfox@mail.nih.gov

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) will accept R34 applications in response to a Request for Applications (RFA), or when NIAAA has specifically agreed to accept an application after discussion between the potential applicant and program staff.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Anna Nicholson
Phone:  301- 451-6513
FAX:     301-480-4543
Email: Nicholsona@mail.nih.gov

Shahnaz Khan, MPH
Phone: 301-451-9893
Fax: 301-480-4543
Email:  khanshah@mail.nih.gov

 

Andrew Jones 
Phone: (301) 435-0610
FAX: (301) 480-5450
Email: jonesan@mail.nih.gov

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)  does not limit R34 applications to Phase III trials and will accept applications for all program areas supported by the Institute. For information regarding specific scientific programs and contacts, see
http://www.niams.nih.gov/Funding/Funding_Opportunities/Supported_Scientific_Areas/default.asp.

National Institute of Child Health and Human Development (NICHD)

Eugene G. Hayunga, Ph.D.
Phone: 301-435-6856
FAX: 301-480-2400
Email:  ehayunga@mail.nih.gov

John Chris Robey
Phone: 301-435-6996
FAX: 301-451-5510
Email:  robeyj@mail.nih.gov

The National Institute of Child Health and Human Development (NICHD) accepts R34 applications for planning of Phase III clinical trials in all program areas supported by the Institute.

National Institute on Drug Abuse (NIDA)

Teresa Levitin, Ph.D.
Phone: 301-443-2755
FAX: 301-443-0538
Email: tlevitin@nida.gov

Diana Haikalis
Phone: 301-443-6710
FAX: 301-594-6849
Email:  dhaikali@nida.nih.gov

The National Institute on Drug Abuse (NIDA) The National Institute on Drug Abuse (NIDA) will accept investigator-initiated R34 applications for all program areas supported by the Institute.

National Eye Institute (NEI)

Dr. Donald F. Everett          
Email: dfe@nei.nih.gov    
   
Dr. Natalie Kurinij
Email: kurinij@nei.nih.gov

Dr. Maryann Redford
Email: redfordm@nei.nih.gov
Phone: 301-451-2020          
FAX for all: 301-402-0528   

William Darby
Phone: 301-435-8179
FAX: 301-496-9997
Email: darbyw@mail.nih.gov

The National Eye Institute (NEI) accepts investigator-initiated R34 applications for all program areas supported by the Institute. The Planning Grant is used to support the development of a detailed MOP and may include preliminary studies to refine study procedures or to document recruitment potential. Applicants may request direct costs up to $150,000 per year for up to two years of support.

Office of Dietary Supplements (ODS)

Dr. Rebecca Costello
Phone: 301-435-3605
FAX: 301 480-1845
Email: CostellB@od.nih.gov

 

The Office of Dietary Supplements (ODS) is a potential source of co-funding to support R34 applications for planning of clinical trials relevant to dietary supplements.

 

NIH Institutes and Centers that Accept NIH Clinical Trial Planning Grant (R34) Applications Under Their Specific FOA(s) ONLY

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sanford Garfield, Ph.D (for behavioral research)
Phone: 301-594-8803
FAX:  301-480-3503
E-mail:  sg50o@nih.gov   

Barbara Linder, M.D., Ph.D. (for pediatric medical research)
Phone: 301-594-0021
FAX: 301-480-3503
E-mail:  bl99n@nih.gov
 
Myrlene Staten, M.D. (for adult medical research)
Phone: 301-402-7886
FAX:  301-480-3503
E-mail:  ms808k@nih.gov

Robert Kuczmarski (for obesity research)
Phone: 301-451-8354
FAX:  301-480-8300
E-mail:  rk191r@nih.gov

 

See PAR-09-177